![Labs on Notice Following Healthcare Fraud Enforcement Action](https://www.g2intelligence.com/wp-content/uploads/2022/07/Aug22.LCA_.QandA_.DanielleTangorre.July20-DOJ-Takedown-iStock-1800x1250-1-1080x675.png)
Labs on Notice Following Healthcare Fraud Enforcement Action
Danielle H. Tangorre discusses key takeaways for labs from the DOJ’s recent nationwide takedown of $1.2 billion in alleged schemes.
Danielle H. Tangorre discusses key takeaways for labs from the DOJ’s recent nationwide takedown of $1.2 billion in alleged schemes.
Last week saw a takedown of $1.2B worth of alleged fraud schemes involving labs, genetic testing, and telemedicine.
The OIG’s new Fraud Alert can help labs and other providers steer clear of potentially suspect arrangements with telemedicine companies.
First Special Fraud Alert in nearly two years cites six red flags of suspect arrangements with telehealth companies.
The new report could be a turning point in the battle to curb payor abuse of preauthorization requirements.